In 2023, the per capita value for throat pastilles and cough drops in Germany stood at an actual figure. The forecast from 2024 onwards indicates a steady per capita value of €1.17 in 2024 and 2025, with a slight increase to €1.18 from 2026 through 2028. This represents a stable market with minimal growth. Year-on-year variations show no significant changes, yielding a negligible Compound Annual Growth Rate (CAGR) over this five-year forecast period.

Future trends to watch for:

Potential market expansion due to increasing consumer health awareness
Impact of product innovations addressing specific consumer needs
Regulatory changes or economic fluctuations affecting consumer spending and product pricing